Last updated: October 25, 2026

Application No. 18/857,222

PROCESSES FOR THE PREPARATION OF FINERENONE

Non-Final OA

Filed

Oct 16, 2024

Priority

Apr 18, 2022 — IN 202211022829 +1 more

Examiner

HASTINGS, ALISON AZAR

Art Unit

1627

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Assia Chemical Inductries Ltd.

OA Round

1 (Non-Final)

This examiner grants 62% of cases after interview

— +42.1% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 88 resolved cases, 2023–2026

Examiner Intelligence

HASTINGS, ALISON AZAR View full profile →

Grants 62% of resolved cases

Career Allowance Rate

55 granted / 88 resolved

+2.5% vs TC avg

Strong +42% interview lift

Without

With

+42.1%

Interview Lift

resolved cases with interview

Typical timeline

3y 4m

Avg Prosecution

53 currently pending

Career history

139

Total Applications

across all art units

Statute-Specific Performance

§101

2.8%

-37.2% vs TC avg

§103

31.3%

-8.7% vs TC avg

§102

19.3%

-20.7% vs TC avg

§112

27.0%

-13.0% vs TC avg

Black line = Tech Center average estimate • Based on career data from 88 resolved cases

Prosecution Timeline

Oct 16, 2024

Application Filed

Sep 17, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

18/014,300

Patent 12766127

ANTI-VIRAL COMPOUNDS AND METHODS FOR SCREENING SAME AND TREATING VIRAL INFECTIONS

3y 9m to grant Granted Oct 20, 2026

17/625,421

Patent 12759987

CARDIAC THERAPEUTIC

4y 9m to grant Granted Oct 13, 2026

17/784,404

Patent 12760001

COMPOSITIONS AND METHODS FOR SYSTEMIC DELIVERY OF Bcl-2 AND Bcl-xL ANTAGONISTS

4y 4m to grant Granted Oct 13, 2026

18/012,434

Patent 12758646

COMBINATION OF ANTIBODY-DRUG CONJUGATE AND CDK9 INHIBITOR

3y 9m to grant Granted Oct 13, 2026

17/638,267

Patent 12728135

CANNABINOID CONCENTRATE AND ISOLATE, METHOD OF OBTAINING THE SAME AND USE THEREOF

4y 6m to grant Granted Sep 08, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

62%

Grant Probability

99%

With Interview (+42.1%)

3y 4m (~1y 3m remaining)

Median Time to Grant

Low

PTA Risk

Based on 88 resolved cases by this examiner. Grant probability derived from career allowance rate.